HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 200 filers reported holding HERON THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.17 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $118,000 | -63.7% | 20,600 | -7.0% | 0.00% | -83.3% |
| Q2 2020 | $325,000 | +8025.0% | 22,146 | +7282.0% | 0.02% | – |
| Q1 2020 | $4,000 | -42.9% | 300 | +2.0% | 0.00% | – |
| Q4 2019 | $7,000 | +250.0% | 294 | +143.0% | 0.00% | – |
| Q2 2019 | $2,000 | -99.1% | 121 | -98.7% | 0.00% | -100.0% |
| Q1 2019 | $221,000 | -72.1% | 9,051 | -63.8% | 0.01% | -73.9% |
| Q3 2018 | $791,000 | -39.7% | 24,986 | -26.0% | 0.05% | -44.6% |
| Q2 2018 | $1,311,000 | +16.1% | 33,748 | -17.5% | 0.08% | +1.2% |
| Q1 2018 | $1,129,000 | +19.6% | 40,910 | -21.6% | 0.08% | +7.9% |
| Q4 2017 | $944,000 | +53.7% | 52,163 | +37.1% | 0.08% | +38.2% |
| Q3 2017 | $614,000 | +1705.9% | 38,043 | +1802.2% | 0.06% | +1275.0% |
| Q3 2016 | $34,000 | -62.2% | 2,000 | -57.9% | 0.00% | -69.2% |
| Q1 2016 | $90,000 | +4400.0% | 4,747 | +4647.0% | 0.01% | – |
| Q3 2015 | $2,000 | -60.0% | 100 | -75.0% | 0.00% | -100.0% |
| Q2 2014 | $5,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 8,648,252 | $238,692,000 | 35.08% |
| Broadfin Capital, LLC | 1,581,416 | $43,647,000 | 6.80% |
| Tavio Capital LLC | 351,729 | $9,708,000 | 4.58% |
| Mesirow Financial Investment Management, Inc. | 33,389 | $922,000 | 3.88% |
| Rubric Capital Management LP | 1,510,008 | $41,676,000 | 3.88% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,666,229 | $45,988,000 | 3.63% |
| First Light Asset Management, LLC | 473,275 | $13,062,000 | 2.87% |
| Asymmetry Capital Management, L.P. | 77,346 | $2,135,000 | 2.67% |
| Copernicus Capital Management, LLC | 108,000 | $2,981,000 | 2.38% |
| BRIDGER MANAGEMENT, LLC | 1,277,560 | $35,261,000 | 2.14% |